Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
•
Primary Care
When do you consider indefinite anticoagulation in someone with first episode of distal/calf vein DVT?
Does your approach in this population differ compared to proximal DVTs?
Related Questions
How would you manage distal DVT in first trimester of pregnancy?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
What are your top takeaways from ISTH 2025?
How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE (hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.)?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
What is your approach to symptomatic superficial thrombosis of the pelvic veins occurring in the immediate postpartum period?